A Thiosulfuric acid (H2S2O3), sodium salt (1:2) CEP of the European Pharmacopoeia monograph is often referred to as a Thiosulfuric acid (H2S2O3), sodium salt (1:2) Certificate of Suitability (COS). The purpose of a Thiosulfuric acid (H2S2O3), sodium salt (1:2) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Thiosulfuric acid (H2S2O3), sodium salt (1:2) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Thiosulfuric acid (H2S2O3), sodium salt (1:2) to their clients by showing that a Thiosulfuric acid (H2S2O3), sodium salt (1:2) CEP has been issued for it. The manufacturer submits a Thiosulfuric acid (H2S2O3), sodium salt (1:2) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Thiosulfuric acid (H2S2O3), sodium salt (1:2) CEP holder for the record. Additionally, the data presented in the Thiosulfuric acid (H2S2O3), sodium salt (1:2) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Thiosulfuric acid (H2S2O3), sodium salt (1:2) DMF.
A Thiosulfuric acid (H2S2O3), sodium salt (1:2) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Thiosulfuric acid (H2S2O3), sodium salt (1:2) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Thiosulfuric acid (H2S2O3), sodium salt (1:2) suppliers with CEP (COS) on PharmaCompass.